Androgen Annihilation Strategy Prolongs rPFS in mCRPC ...Middle East

Medscape - News
Adding apalutamide to standard care significantly slows progression of chemotherapy-naive metastatic castration-resistant prostate cancer, according to the final results of a phase 3 trial. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Androgen Annihilation Strategy Prolongs rPFS in mCRPC )

Apple Storegoogle play

Also on site :